US STOCKS-Futures tumble as stimulus doubts resurface

  • Reuters
  • Stock Market News
US STOCKS-Futures tumble as stimulus doubts resurface
Credit: © Reuters.

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.)

* Futures down: Dow 0.9%, S&P 1%, Nasdaq 1%

By Shriya Ramakrishnan

Dec 11 (Reuters) - U.S. stock index futures fell 1% on Friday as delays over a new fiscal stimulus package and surging coronavirus infections dented sentiment even as regulators moved toward emergency use authorization of a COVID-19 vaccine.

With fresh business restrictions in many states and a jump in weekly jobless claims, investors are counting on more fiscal relief to sustain a nascent economic recovery.

But an agreement remains elusive and House Speaker Nancy Pelosi on Thursday raised the possibility of negotiations dragging on through Christmas. stocks, which stand to benefit from an economic recovery, led declines in premarket trading on Friday, with energy, industrial and financial sectors all lower.

Major banks Wells Fargo (NYSE: WFC ) & Co WFC.N and JPMorgan Chase & Co (NYSE: JPM ) JPM.N slid more than 1%, while industrial bellwethers Boeing (NYSE: BA ) Co BA.N and 3M (NYSE: MMM ) Co MMM.N fell 1.6% and 0.9%, respectively.

The benchmark S&P 500 .SPX and the blue-chip Dow .DJI were set to snap a two-week winning streak as volatility .VIX jumped to its highest in almost a month.

At 06:29 a.m. ET, Dow E-minis 1YMcv1 were down 270 points, or 0.89%, S&P 500 E-minis EScv1 were down 37.5 points, or 1.02%, and Nasdaq 100 E-minis NQcv1 were down 125.75 points, or 0.98%.

Global stock markets were also subdued after scaling record highs earlier this week as the UK became the first country in the world to begin a mass COVID-19 vaccination program. MKTS/GLOB

A panel of outside advisers to the U.S. Food and Drug Administration on Thursday voted overwhelmingly to endorse emergency use of Pfizer (NYSE: PFE )'s PFE.N COVID-19 vaccine, sending shares of the drugmaker up 1.9% in premarket trading. MA.N dropped 1.4% after the UK Supreme Court gave the green light for a $18.5 billion class action against the company for allegedly overcharging more than 46 million people in Britain over a 15-year period.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or


Related Articles